Project Grant R01DA062399
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $183,681 to Michigan State University (in partnership with Henry Ford Health) on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a patient-engaged technology-based intervention reducing prenatal cannabis use. The research deliverables include the development of an Electronic Screening and Brief Intervention (ESBI) platform combined with...
- Federal Project Grant Award Summary The University of Michigan, Office of Research and Sponsored Projects, received a $429,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2026, through May 31, 2028. This research initiative examines substances, behaviors, and outcomes associated with adolescent reporting to North Carolina's statewide technology-facilitated reporting system (TFRS)—a...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $386,301 to the Regents of the University of Michigan under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic neuroscience research investigating axonal mechanisms regulating dopamine release in the striatum. The five-year project, initiated May 1, 2026 and concluding February 28, 2031, will utilize direct axonal voltage recording techniques to elucidate how striatal cholinergic...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant totaling $686,692 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct prospective research on cannabis use reduction and its impact on patient functioning. Initiated on September 1, 2025, and extending through July 31, 2030, this eight-week clinical trial will enroll 176 adults aged 18 and older with Cannabis Use Disorder...
- Summary The University of Michigan received a $1,139,062 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 15, 2026 through February 28, 2031. This R01 research project will develop and test the efficacy of Health Check-Up for Expectant Moms Plus (HCEM+), an enhanced web-delivered screening, brief intervention, and referral to treatment or prevention (SBIRT/P) program tailored for rural pregnant...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $295,896 to Michigan State University's Henry Ford Health + Michigan State University Health Sciences partnership, effective March 15, 2026, through February 29, 2028, under the Drug Use and Addiction Research Programs (CFDA 93.279). The project will develop and validate an epigenetic risk scoring tool based on DNA methylation (DNAm) profiles to objectively assess polysubstance use (PSU) and...
- Federal Grant Award Summary Michigan State University received a $495,345 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 1, 2026, with completion targeted for March 31, 2031. The award supports fundamental neuroscience research investigating the role of neuromedin S (NMS) expression and signaling in the ventral tegmental area (VTA) and its contribution to opioid response and addiction-related behaviors. The...
- Federal Grant Award Summary The Public Health Institute received a $542,187 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with completion targeted for March 31, 2031. The grant funds a longitudinal research study examining cannabis use patterns among residents in sober living houses (SLHs)—abstinence-based recovery environments. The project will recruit 35 SLHs and 400 residents (200 with...
- Federal Grant Award Summary Michigan State University (operating as Henry Ford Health+Michigan State University Health Sciences) received a $766,538 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on September 15, 2025, with completion targeted for May 31, 2028. The award funds development and evaluation of an adaptive psychological intervention designed to reduce prolonged opioid use among patients hospitalized for...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
The National Institute on Drug Abuse (NIDA) awarded the Regents of the University of Michigan a $701,964 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a remote, behavioral economics-based intervention for cannabis use disorder (CUD). The project, initiated on June 15, 2026, and concluding March 31, 2031, addresses the critical gap in CUD treatment accessibility, as fewer than 10% of individuals with CUD currently receive care despite affecting approximately 22% of cannabis users. The intervention leverages virtual videoconferencing delivery and behavioral economic approaches to substitute healthier behaviors for cannabis use, designed to engage non-treatment-seeking individuals who would otherwise remain outside traditional substance use disorder treatment systems while supporting harm reduction and wellbeing outcomes. This research initiative builds on prior work conducted by the University of Michigan in virtually-delivered substance use interventions and aims to increase CUD treatment engagement by reducing barriers associated with traditional in-person care, including stigma and accessibility challenges. The virtually-delivered format allows patients to receive care in preferred locations while enabling proactive outreach to the substantial population of individuals with CUD who are not actively seeking conventional treatments. The project represents an implementation science approach to expand evidence-based treatment access within the Drug Use and Addiction Research Programs portfolio, which supports research spanning prevention, diagnosis, and treatment of substance use disorders and related health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $702.0k | 6/8/26 |